Enriching Elderly Mesenchymal Stem Cells via Young ECM Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The quantity and quality of mesenchymal stem cells (MSCs) decline with age, limiting the effectiveness of stem cell therapies for age-related degenerative diseases, as existing methods fail to effectively isolate and expand functional MSCs from elderly individuals.
Innovation Solution
A method involving the isolation and expansion of small-sized, SSEA-4 positive mesenchymal stem cells from elderly donors, which are cultured on extracellular matrix derived from young donors to enhance their regenerative potential, thereby restoring the regenerative capability of bone marrow stromal cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If mesenchymal stem cells are harvested from elderly donors, then the cells can be used for autologous therapy, but the quantity and quality of the cells are severely diminished
Solution Approach 1:
The patent segments the heterogeneous MSC population by size, isolating a specific subpopulation of small-sized cells (median diameter <30 microns) that exhibit enhanced regenerative properties. This segmentation allows enrichment of functional cells from the overall MSC population, resolving the contradiction between using elderly donor cells and maintaining therapeutic effectiveness.
Solution Approach 2:
The patent applies local quality by creating a young donor-derived extracellular matrix microenvironment that selectively enhances the regenerative properties of small-sized MSCs from elderly donors. This localized environmental modification rescues the functional capacity of specific cells without requiring replacement of the entire cell population.
2Productivity
If standard culture methods are used for elderly MSCs, then the cells can be expanded, but the regenerative potential remains compromised
Solution Approach 1:
The patent introduces young donor extracellular matrix as an intermediary substance that mediates between the elderly MSCs and the culture environment. This ECM intermediary provides biochemical and physical signals that rescue the regenerative potential of elderly MSCs while maintaining their expandability, resolving the contradiction between cell expansion and functional preservation.
Solution Approach 2:
The patent changes the cultural parameters by using young donor ECM instead of standard culture conditions. This parameter change (ECM source age) selectively enhances the regenerative properties of small-sized MSCs from elderly donors, allowing both expansion and functional rescue simultaneously.
3Productivity
If polymeric scaffolds are used to support MSC proliferation, then cell growth is enhanced, but inflammation is induced due to acidic degradation products
Solution Approach 1:
The patent replaces long-lasting polymeric scaffolds with a biodegradable natural ECM product that breaks down into non-inflammatory components. This ECM, derived from young donor cells, serves as a temporary supportive structure that degrades safely, resolving the contradiction between enhancing cell proliferation and avoiding inflammatory responses.
Data Source
AI summary
Methods of, treatments using, and devices for restoring the regenerative capability for mesenchymal stem cells and isolating and expanding a small subpopulation of less defective mesenchymal stem cells from the bone marrow stromal cells of people with decreased quality and/or quantity of mesenchymal stem cells, such as elderly people.